Zeng and colleagues noted that while the use of a tyrosine kinase inhibitor plus an immune checkpoint inhibitor has become ...

Sanofi has received orphan designation from the European Medicines Agency (EMA) for rilzabrutinib, a reversible covalent ...

Culver City-based ImmunityBio Inc. has started to take its Anktiva immunotherapy drug global. Last month, the United Kingdom ...

WuXi Biologics (Stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today ...

A new study published in The American Journal of Psychiatry showed that esketamine nasal spray monotherapy significantly ...

Airway Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel biologic therapies for respiratory, inflammatory, and infectious diseases, today announced that the European ...

Ascentage Pharma (AAPG) announced that it has received clearance by the U.S. Food and Drug Administration, FDA, and the European Medicines Agency, ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

The European Medicines Agency’s human medicines committee has recommended that BeOne Medicines’ Tevimbra (tislelizumab) be ...

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

Cash, cash equivalents, and short-term investments stood at $227.0 million as of Q2 2025, expected to fund operations into the fourth quarter of 2026 based on balances as of June 30, 2025. These 10 ...